3 recruiting, 1 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 3, Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Schizoaffecitve Disorder: new trials by email Literature Review of Schizoaffecitve Disorder trials Research Report on Schizoaffecitve Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia EEG Neurofeedback - SCHIZOPHRENIA 1 (Disorder), Schizoaffecitve Disorder | Phase 2 | Recruiting | University of California, San Diego | 104 | 2026-11-05 | 2026-11-10 |
| Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia Deferiprone (DFP), N-Acetyl Cysteine (NAC) - Schizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder | Phase 2 | Recruiting | Amit Lotan | 80 | 2026-08-12 | 2026-09-29 |
| A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia Xanomeline and trospium chloride (KarXT) - SCHIZOPHRENIA 1 (Disorder), Schizoaffecitve Disorder | Phase 1 / Phase 2 | Recruiting | New York State Psychiatric Institute | 12 | 2026-07-01 | 2026-07-14 |
| Glycine to Treat Psychotic Disorders in Children Glycine - Psychotic Disorder, Schizoaffecitve Disorder | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 10 | 2000-05-01 | 2008-03-04 |
Schizophrenia (3) · Psychotic Disorders (2)
Mental Disorders (3) · Schizophrenia Spectrum and Other Psychotic Disorders (3)
Acetylcysteine (1) · Deferiprone (1) · Glycine (1) · trospium chloride (1) · xanomeline (1)
Amit Lotan (1) · National Institute of Mental Health (NIMH) (1) · New York State Psychiatric Institute (1) · University of California, San Diego (1)
United States (3) · Israel (1)
Fiza Singh, MD (1) · Joshua T Kantrowitz, MD (1) · Ragy Girgis, MD (1)